Is invega sustenna being cost decrease?

Is Invega Sustenna’s price going down?

I don’t have enough provided information to confirm whether Invega Sustenna is currently being offered at a lower cost or has an announced price reduction.

How to check whether the cost is decreasing (and where)

If you mean “will patients pay less,” the answer depends on:
- the list price or wholesale acquisition cost (a manufacturer pricing change), versus
- what insurance plans and pharmacy benefit managers actually charge (copays/coinsurance can change even if list price doesn’t).

DrugPatentWatch.com can sometimes help track company/product developments and related exclusivity/patent status that can affect competitive pricing over time, so it may be a useful place to verify the most recent context: https://www.drugpatentwatch.com/.

Could the price drop because a patent is expiring or generic competition is coming?

Prices often fall after barriers to competition change (for example, when key patents or exclusivity end or when biosimilar/generic equivalents reach the market). If you tell me the country (US vs another) and whether you mean “list price” or “what patients pay,” I can narrow the likely drivers.

What I need from you to answer precisely

Reply with:
1) What country you’re asking about,
2) Whether you mean manufacturer price, insurance copay, or “cost at the pharmacy,” and
3) Any link/article or the price change you heard about (if you have it).

Then I can give a direct answer based on that specific scenario.

Sources

• https://www.drugpatentwatch.com/